Neuronetics (STIM) Cash from Investing Activities (2017 - 2026)
Neuronetics' (STIM) quarterly Cash from Investing Activities came in at -$172000.0 in Q1 2026, up 21.46% year-on-year from -$141609.0 in Q1 2025, and up 20.37% on a QoQ basis from -$216000.0 in Q4 2025.
Neuronetics (STIM) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Cash from Investing Activities data on file, last reported at -$172000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 21.46% year-over-year to -$172000.0 in Q1 2026; TTM through Mar 2026 was -$754000.0, a 72.07% increase from a year earlier, with the FY2025 full-year figure at -$801000.0, up 66.8% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$172000.0, up from -$216000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for STIM reached as high as $9.3 million in Q3 2022 and fell as low as -$2.4 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged $119000.0 across 5 years, with a median of -$216000.0 in 2025.
- Across the five-year window, Cash from Investing Activities jumped 216.95% in 2022 and tumbled 914.29% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$503000.0 in 2022, then slipped by 11.93% to -$563000.0 in 2023, then tumbled by 322.02% to -$2.4 million in 2024, then soared by 90.91% to -$216000.0 in 2025, then rose by 20.37% to -$172000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$172000.0 in Q1 2026, -$216000.0 in Q4 2025, and -$114000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Neuronetics | 123.52 Mn | 117.51 Mn | 16.15 Mn | -172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Mar 31, 2025 | -219,000.00 |
| Mar 31, 2025 | -219,000.00 |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | -563,000.00 |
| Dec 31, 2023 | -563,000.00 |